Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Song

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Pharmaceutical Statistics|June 27, 2022
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomesGaohong Dong, Bo Huang, Johan Verbeeck, et al.
Breast Cancer Research : BCR|July 9, 2016
"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapyChristopher Twelves, Javier Cortes, Peter A Kaufman, et al.
The Journal of Investigative Dermatology|September 7, 2025
Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and PolicyJoshua Burshtein, Christopher G Bunick, Ruth Ann Vleugels, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2025
Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary InfectionLawrence A Schachner, Adelaide A Hebert, Robert Sidbury, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2016
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid CancerBruce Robinson, Martin Schlumberger, Lori J Wirth, et al.
Journal of Lipid Research|October 28, 2010
Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopyLei Zhang, James Song, Giorgio Cavigiolio, et al.
Future Oncology (London, England)|April 11, 2019
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaShukui Qin, Richard S Finn, Masatoshi Kudo, et al.
Molecular Cancer Therapeutics|May 20, 2017
A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own DemiseHui Zhao, Sara Gulesserian, Maria Christina Malinao, et al.
Circulation. Cardiovascular Imaging|April 21, 2011
Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunctionZakir H Sahul, Rupak Mukherjee, James Song, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Pharmaceutical Statistics|June 27, 2022
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomesGaohong Dong, Bo Huang, Johan Verbeeck, et al.
Breast Cancer Research : BCR|July 9, 2016
"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapyChristopher Twelves, Javier Cortes, Peter A Kaufman, et al.
The Journal of Investigative Dermatology|September 7, 2025
Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and PolicyJoshua Burshtein, Christopher G Bunick, Ruth Ann Vleugels, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2025
Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary InfectionLawrence A Schachner, Adelaide A Hebert, Robert Sidbury, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2016
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid CancerBruce Robinson, Martin Schlumberger, Lori J Wirth, et al.
Journal of Lipid Research|October 28, 2010
Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopyLei Zhang, James Song, Giorgio Cavigiolio, et al.
Future Oncology (London, England)|April 11, 2019
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaShukui Qin, Richard S Finn, Masatoshi Kudo, et al.
Molecular Cancer Therapeutics|May 20, 2017
A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own DemiseHui Zhao, Sara Gulesserian, Maria Christina Malinao, et al.
Circulation. Cardiovascular Imaging|April 21, 2011
Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunctionZakir H Sahul, Rupak Mukherjee, James Song, et al.
Pageof 10